圣诺医药-B(02257)于2026年3月4日发布2026年2月股份变动月报表。公告显示，截至2026年2月28日，公司注册股本维持在230,000美元，普通股每股面值为0.001美元，合计注册股份数目为230,000,000股。
根据公告，公司于本月末已发行普通股数量仍为107,221,538股，与上月持平。本月内未有新增发行股份或购回、注销及库藏股变动，公共持股量亦符合相关监管要求。
在公司股份期权及激励计划方面，截至2026年2月28日，根据现有购股权计划，本月无行使、授出或注销情况，已授出的股份期权数目为731,679份，未导致公司已发行股本变化。
公告提及，公司已确认遵守香港联合交易所有限公司上市规则及其他相关法律规定。该报告由公司秘书袁润廷签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.